1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. ORGANS ON CHIP MARKET BY OFFERING
5.1. Introduction
5.2. Products
5.3. Services
6. ORGANS ON CHIP MARKET BY ORGAN TYPE
6.1. Introduction
6.2. Liver
6.3. Lungs
6.4. Kidney
6.5. Heart
6.6. Others
7. ORGANS ON CHIP MARKET BY APPLICATION
7.1. Introduction
7.2. Drug Discovery
7.3. Regenerative Medicine
7.4. Disease Modeling
7.5. Others
8. ORGANS ON CHIP MARKET BY END-USER
8.1. Introduction
8.2. Pharmaceutical & Biotech Companies
8.3. Research & Academic Institutes
8.4. Others
9. ORGANS ON CHIP MARKET BY GEOGRAPHY
9.1. Introduction
9.2. Americas
9.2.1. USA
9.2.2. Others
9.3. Europe Middle East and Africa
9.3.1. Germany
9.3.2. United Kingdom
9.3.3. Others
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.4.4. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. CN Bio Innovations Ltd
11.2. Emulate Inc.
11.3. BiomimX S.r.l.
11.4. InSphero
11.5. MIMETAS
11.6. TissUse GmbH.
11.7. Hesperos, Inc.
11.8. AlveoliX
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES